Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors
Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa Abu‐Khalaf, Daniel P. Silver, Juan Palazzo, Geetha Jagannathan, Frederick Fellin, Saveri Bhattacharya, Rebecca Jaslow, Theodore N. Tsangaris, Adam C. Berger, Manish Neupane, Terrence P. Cescon, AnaMaria Lopez, Kaelan Yao, Weelic Chong, Brian Lu, Ronald E. Myers, Lifang Hou, Qiang Wei, Bingshan Li, Massimo Cristofanilli, Hushan Yang
Topics & Concepts
MedicineHazard ratioInternal medicineOncologyBreast cancerProportional hazards modelConfidence intervalStage (stratigraphy)Univariate analysisCancerProgression-free survivalMultivariate analysisChemotherapyPaleontologyBiologyHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies